esophageal adenocarcinoma and high-grade dysplasia in this fashion," says senior study author Stephen Meltzer, M.D., professor of medicine and oncology and the Harry and Betty Myerberg/Thomas R.

Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up ...

The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear ... When possible, the luminal location of the tumor before therapy was defined endoscopically ...

esophageal adenocarcinoma and high-grade dysplasia in this fashion," says senior study author Stephen Meltzer, M.D., professor of medicine and oncology and the Harry and Betty Myerberg/Thomas R.

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment locally at low-volume centers, according to results of a cohort ...

A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal squamous cell carcinoma (ESCC), according ...

Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene 23(2), 554-558 (2004). Jankowski J, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's ...

Researchers conducted a retrospective study to determine whether perioperative chemotherapy offered better outcomes than preoperative chemoradiotherapy for resectable locally advanced esophageal ...